

The Paxlovid API market research report highlights a growing demand for antiviral medications amidst the ongoing pandemic, resulting in a promising market outlook. The market size for Paxlovid API is expected to reach a significant value in the coming years, driven by increased adoption and investment in healthcare infrastructure. Request Sample Report
◍ Pfizer
◍ Nanjing Hicin Pharmaceutical
◍ Lepu Medical
◍ HAS Biotech
◍ Novasep
The competitive landscape of the Paxlovid API Market includes key players like Pfizer, Nanjing Hicin Pharmaceutical, Lepu Medical, HAS Biotech, and Novasep. These companies manufacture and supply Paxlovid active pharmaceutical ingredients, contributing to the growth of the market. Sales revenue for some of these companies: Pfizer - $81.3 billion, Novasep - $423 million.
◍ COVID-19 Oral Drugs
◍ Research Reagents
◍ Other
◍ Purity ≥99%
◍ Purity ≥99.5%